We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+21.26%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.97B
AUM Growth
+$710M
Cap. Flow
+$33.6M
Cap. Flow %
0.68%
Top 10 Hldgs %
43.85%
Holding
701
New
35
Increased
130
Reduced
246
Closed
41

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$31M
2
BTI icon
British American Tobacco
BTI
+$29.2M
3
SAP icon
SAP
SAP
+$27.1M
4
HOOD icon
Robinhood
HOOD
+$17.9M
5
CLS icon
Celestica
CLS
+$13.7M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$29.1M
2
TSM icon
TSMC
TSM
+$26.3M
3
META icon
Meta Platforms (Facebook)
META
+$23.5M
4
BEKE icon
KE Holdings
BEKE
+$22.1M
5
TCOM icon
Trip.com Group
TCOM
+$17M

Sector Composition

Rank Sector Weight
1 Technology 46.19%
2 Consumer Discretionary 14.25%
3 Communication Services 13.85%
4 Healthcare 7.17%
5 Consumer Staples 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLYM
551
DELISTED
Plymouth Industrial REIT
PLYM
$11.8K ﹤0.01%
732
-34
-4% -$531
NI icon
552
NiSource
NI
$21.9B
$11.7K ﹤0.01%
290
– –
AUTL
553
Autolus Therapeutics
AUTL
$386M
$11.7K ﹤0.01%
5,113
– –
DTE icon
554
DTE Energy
DTE
$30.4B
$11.5K ﹤0.01%
87
– –
KURA icon
555
Kura Oncology
KURA
$826M
$11.5K ﹤0.01%
1,991
– –
GOOD
556
Gladstone Commercial Corp
GOOD
$627M
$11.4K ﹤0.01%
795
-37
-4% -$525
FTRE icon
557
Fortrea Holdings
FTRE
$1.96B
$11.3K ﹤0.01%
2,296
– –
AEE icon
558
Ameren
AEE
$31.1B
$11.3K ﹤0.01%
118
– –
CGEM icon
559
Cullinan Oncology
CGEM
$1.07B
$11.2K ﹤0.01%
1,491
– –
PPL
560
PPL Corp
PPL
$27.3B
$11.1K ﹤0.01%
327
– –
CMS icon
561
CMS Energy
CMS
$23B
$10.9K ﹤0.01%
158
– –
AMLX icon
562
Amylyx Pharmaceuticals
AMLX
$2.17B
$10.9K ﹤0.01%
1,700
– –
DHC
563
Diversified Healthcare Trust
DHC
$2.23B
$10.8K ﹤0.01%
3,013
-146
-5% -$421
TRVI icon
564
Trevi Therapeutics
TRVI
$2.62B
$10.8K ﹤0.01%
1,968
– –
RAPP
565
Rapport Therapeutics
RAPP
$2.01B
$10.6K ﹤0.01%
936
– –
TRML
566
DELISTED
Tourmaline Bio
TRML
$10.5K ﹤0.01%
656
– –
RGNX icon
567
Regenxbio
RGNX
$615M
$10.4K ﹤0.01%
1,269
– –
PGEN icon
568
Precigen
PGEN
$1.97B
$10.3K ﹤0.01%
7,259
– –
ORKA
569
Oruka Therapeutics
ORKA
$5.46B
$10K ﹤0.01%
896
– –
SVRA icon
570
Savara
SVRA
$1.09B
$10K ﹤0.01%
4,395
– –
LKFT
571
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
$9.99K ﹤0.01%
357
– –
INN
572
Summit Hotel Properties
INN
$743M
$9.87K ﹤0.01%
1,939
-94
-5% -$414
AHRT
573
AH Realty Trust
AHRT
$540M
$9.8K ﹤0.01%
1,427
-69
-5% -$479
WSR
574
DELISTED
Whitestone REIT
WSR
$9.71K ﹤0.01%
778
-37
-5% -$471
SITC icon
575
SITE Centers
SITC
$235M
$9.56K ﹤0.01%
845
-40
-5% -$479
21 22
23
24 25

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return

GF Fund Management's Q2 2025 Portfolio in Review

As of Q2 2025, GF Fund Management held 701 positions worth $4.97B, up 17% from $4.26B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

GF Fund Management's Q2 2025 filing shows 35 new, 130 increased, 246 reduced and 41 closed positions. Its largest new stake was Shopify: 120,000 shares worth $13.8M. The largest sale was NVIDIA, an estimated $29.1M.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 42% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • GF Fund Management's largest Q2 2025 buy was Shopify: 120,000 shares worth $13.8M.
  • GF Fund Management added most to UnitedHealth in Q2 2025, an estimated $31M increase.
  • GF Fund Management's biggest Q2 2025 reduction was NVIDIA, cutting an estimated $29.1M.
  • GF Fund Management fully exited Salesforce in Q2 2025, selling an estimated $9.77M.
  • GF Fund Management's ten largest holdings make up 44% of its $4.97B portfolio in Q2 2025.
  • GF Fund Management opened 35 new positions and closed 41 in Q2 2025.
  • GF Fund Management's portfolio value rose 17% quarter-over-quarter to $4.97B.

Based on GF Fund Management's 13F filing for Q2 2025, filed 22 Jul 2025.